Cannabidiol: an anxiolytic or an antipsychotic new drug? (2011)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- Subjects: ESQUIZOFRENIA; INTERAÇÃO SOCIAL (COMPORTAMENTO SOCIAL); CANNABIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Programa
- Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental (FeSBE)
-
ABNT
PERES, F. F. et al. Cannabidiol: an anxiolytic or an antipsychotic new drug? 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 04 mar. 2026. -
APA
Peres, F. F., Almeida, V., Levin, R., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., et al. (2011). Cannabidiol: an anxiolytic or an antipsychotic new drug? In Programa. São Paulo: FeSBE. -
NLM
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2026 mar. 04 ] -
Vancouver
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2026 mar. 04 ] - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
